• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2024, Vol. 26 ›› Issue (1): 48-52.

• 精准医疗良好实践案例:创新实践 • 上一篇    下一篇

瑞典精准医疗发展的成功实践与挑战

李梅钰12, 韩洞明12, 李建康1, 高雅1, 金鑫1*   

  1. 1.深圳华大生命科学研究院,广东 深圳 518083;
    2.中国科学院大学生命科学学院,北京 100049
  • 收稿日期:2024-01-04 出版日期:2024-01-28 发布日期:2024-01-28
  • 基金资助:
    国家重点研发计划资助项目,科技部重点研发计划“政府间国际科技创新合作”重点专项[项目编号:2021YFE0192400;项目名称:中国-欧盟国际精准医疗领域合作支持计划(IC2PerMed)]

Successful Practices and Challenges in the Development of Precision Medicine in Sweden

  1. 1.BGI Research Guangdong Shenzhen 518083, China
    2.College of Life Sciences University of Chinese Academy of Sciences Beijing 100049, China
  • Received:2024-01-04 Online:2024-01-28 Published:2024-01-28

摘要:

不同国家在医疗领域的政策和实践差异是由各国的文化、社会结构、经济状况和政治体制等多方面因素所驱动。尽管国情不同,全球共同目标是一致的,那就是推动医疗领域的进步,以提供更好的医疗护理和治疗方案,最大程度地满足患者的需求。国际精准医疗联盟(ICPerMed)参与全球协作,旨在促进和支持个性化医疗的发展和应用。其中,瑞典作为ICPerMed的主要成员之一,展示了个性化医疗和精准医疗领域的巨大潜力。鉴于此,本研究拟对瑞典精准医疗体系架构的建立背景、实施过程以及现存问题进行综述。该项目的成功经验将为包括中国在内的其他国家精准医学的发展提供重要借鉴。同时,尽管取得了显著成就,瑞典精准医疗的发展依然面临许多不足和挑战,例如数据隐私、社会伦理,以及大规模基因测序成本较高等,这些都有待不断改进和创新以进一步推动个性化医疗领域的前进。


关键词: 国际精准医疗联盟, 精准医疗, 瑞典

Abstract:

Differences in policies and practices in the healthcare sector among various countries are driven by multifaceted factors such as culture social structure economic conditions and political systems. Despite varying national circumstances the global shared objective remains consistent that is to advance the healthcare sector to offer improved medical care and treatment solutions cater extensively to patients' needs. International Consortium for Personalized Medicine ICPerMed engages in global collaborations aiming at fostering and supporting the development and application of personalized medicine. As a key member of ICPerMedSweden has showcased significant potential in the field of personalized and precision medicine. Hence this study aims to review the establishment background implementation processes and existing issues within Sweden's precision medicine framework. The success experiences of this initiative will serve as valuable reference points for the development of precision medicine in other countries including China. However despite significant achievements Sweden's precision medicine development encounters several shortcomings and challenges such as data privacy social ethics and the high costs associated with large-scale genetic sequencing all of which require continuous improvement and innovation to further propel advancements in the field of personalized healthcare.


Key words: ICPerMed , Precision medicine , Sweden

中图分类号: